Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone effectively makes hair shafts thinner in women with excessive hair growth.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Different substances affect hair and skin cell growth in various ways.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Cyclosporin A and FK506 can start new hair growth in mice, but ascomycin and rapamycin cannot.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

New treatments improve hair loss solutions for different age groups and genders.

Minoxidil helps with hair regrowth in women with androgenic alopecia.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.